CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandey, C. K.
Right arrow Articles by Singh, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandey, C. K.
Right arrow Articles by Singh, P. K.
Canadian Journal of Anesthesia 52:172-175 (2005)
© Canadian Anesthesiologists' Society, 2005

General Anesthesia

Intravenous lidocaine 0.5 mg·kg–1 effectively suppresses fentanyl-induced cough

[L’administration iv de 0,5 mg·kg–1 de lidocaïne supprime efficacement la toux induite par le fentanyl]

Chandra Kant Pandey, MD, Mehdi Raza, MD, Rajeev Ranjan, MD, Vinay Singhal, MD, Mukesh Kumar, MD, Archana Lakra, MD, Deepa Vishwas Navkar, MD, Anil Agarwal, MD, Ram Badan Singh, MD PDCC, Uttam Singh, PhD and Prabhat Kumar Singh, MD

From the Departments of Anaesthesiology and Biostatistics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Address correspondence to: Dr. Chandra Kant Pandey, Associate Professor, Department of Anaesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India. Phone: 91-522-440715 or 719, ext. 2490; Fax: 91-522-440017, 440078, attention to Dr. C. K. Pandey; E-mail: ckpandey{at}sgpgi.ac.in

Purpose: To evaluate the minimal dose of lidocaine required for suppression of fentanyl-induced cough.

Methods: 320 ASA I and II patients, non-smokers of both sexes scheduled for elective surgery between the ages of 18 to 60 yr were randomly allocated into four equal groups. The patients were assigned to receive lidocaine 0.5 mg·kg–1 (Group I), 1.0 mg·kg–1(Group II), 1.5 mg·kg–1 (Group III) or placebo (Group IV) over five seconds, one minute prior to the administration of fentanyl 3 µg·kg–1 in a randomized and double-blind fashion. Any episode of cough was classified as coughing and graded as mild (1–2) moderate (3–4) or severe (5 or more). The data were analyzed by test of proportion.

Results: Eleven, 12, 11 and 28 patients (13.75%, 15%, 13.75% and 35%) had cough in Groups I, II, III and IV respectively (P < 0.05 Groups I, II, III vs IV). There was no significant difference in the incidence and severity of cough among the lidocaine pretreated groups (P > 0.05).

Conclusion: The results of our study suggest that iv lidocaine 0.5 mg·kg–1 is the minimal dose required to suppress fentanyl-induced cough when administered one minute prior to fentanyl. Any further increase in the lidocaine dose does not reduce the incidence or severity of fentanyl-induced cough.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. Y. Kim, J. Y. Kim, Y. B. Kim, and H. J. Kwak
Pretreatment with remifentanil to prevent withdrawal after rocuronium in children
Br. J. Anaesth., January 1, 2007; 98(1): 120 - 123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Canadian Anesthesiologists' Society.